arrow
A

Anna Paczkowska

poznan university of medical sciences
H指数:11
被引数:471

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

When diabetic ketoacidosis becomes a neurological emergency: cerebral edema in a child with new-onset type 1 diabetes mellitus - a case report and narrative review

当糖尿病酮症酸中毒成为神经急症:1型糖尿病新发儿童患者并发脑水肿——病例报告与叙述性综述

2026-09-290
OA
Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes

通过益生元、益生菌、合生元和后生元靶向肠道-骨骼轴:从机制可行性到临床骨骼结局

2026-09-110
OA
Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer

肿瘤代谢:在癌基因信号、表观遗传学和免疫学交叉点上的新兴癌症治疗策略

2026-07-170
OA
Natural supplements in breast cancer therapy: translational evidence; clinical safety; and emerging challenges

天然补充剂在乳腺癌治疗中的应用:转化医学证据;临床安全性;及新兴挑战

2026-04-300
OAAI
COVID-19 vaccination remains essential for healthcare professionals: clinical evidence from a Polish cross-sectional study

COVID-19疫苗接种对医疗专业人员仍至关重要:来自波兰横断面研究的临床证据

2026-04-160
OAAI
Correction: Redefining pancreatogenic diabetes mellitus through molecular; imaging; and AI-driven evidence

更正:通过分子、影像学和人工智能驱动的证据重新定义胰腺源性糖尿病 mellitus

2026-04-080
OAAI
Recent Advances in Medicinal Chemistry on PqsR in Pseudomonas Aeruginosa: Scaffold Optimization, SAR Insights, and Natural Product Modulators

《铜绿假单胞菌中PqsR的药物化学最新进展:骨架优化、SAR洞察与天然产物调节剂》

2026-03-070
OAAI
Vitamin D supplementation and selected metabolic parameters in patients with type 2 diabetes and obesity: a prospective observational study

维生素D补充剂及选定代谢参数在2型糖尿病和肥胖患者中的研究:一项前瞻性观察性研究

2026-01-150
OAAI
Relative Effectiveness and Safety of the GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists; Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics: A Prospective Observational Cohort Study in Poland

GLP-1(胰高血糖素样肽1)受体激动剂在治疗肥胖2型糖尿病患者中的相对有效性与安全性:一项在波兰进行的预期性观察队列研究;Semaglutide和Liraglutide

2025-08-070
OA